Home

rozet Şirketimiz Kayıt teva financial calendar Okunabilirlik Sarkma bin

Israel's TEVA, PERI Tank on Q4 Earnings; IZRL in Focus - TipRanks.com
Israel's TEVA, PERI Tank on Q4 Earnings; IZRL in Focus - TipRanks.com

Teva Pharmaceuticals reports earnings on Wednesday. Here's what to expect -  MarketWatch
Teva Pharmaceuticals reports earnings on Wednesday. Here's what to expect - MarketWatch

Teva taps Netsmart to take over HQ lease in Overland Park - Kansas City  Business Journal
Teva taps Netsmart to take over HQ lease in Overland Park - Kansas City Business Journal

Teva Bonds: 8.8% Yield To Maturity Understates Upside | Nasdaq
Teva Bonds: 8.8% Yield To Maturity Understates Upside | Nasdaq

Infographic: Teva Pharmaceuticals (TEVA) Q1 2021 earnings results |  AlphaStreet
Infographic: Teva Pharmaceuticals (TEVA) Q1 2021 earnings results | AlphaStreet

Analyst Ratings for Teva Pharmaceutical Indus | Markets Insider
Analyst Ratings for Teva Pharmaceutical Indus | Markets Insider

Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg

Teva Reports First Quarter 2020 Financial Results | Business Wire
Teva Reports First Quarter 2020 Financial Results | Business Wire

Catalyst Pharma Shares Take A Hit As Teva Files For Generic Version Of Its  Lead Product | Markets Insider
Catalyst Pharma Shares Take A Hit As Teva Files For Generic Version Of Its Lead Product | Markets Insider

TEVA Earnings Date 2023 | Teva Pharmaceutical Industries Earnings Forecast
TEVA Earnings Date 2023 | Teva Pharmaceutical Industries Earnings Forecast

Drugmaker Teva Misled Court to Dodge Opioid Trial, New York State Claims -  Bloomberg
Drugmaker Teva Misled Court to Dodge Opioid Trial, New York State Claims - Bloomberg

TEVA PHARMACEUTICAL INDUSTRIES LIMITED : TEVA Stock Price | IL0006290147 |  MarketScreener
TEVA PHARMACEUTICAL INDUSTRIES LIMITED : TEVA Stock Price | IL0006290147 | MarketScreener

Infographic: Teva Pharmaceuticals (TEVA) Q1 2021 earnings results |  AlphaStreet
Infographic: Teva Pharmaceuticals (TEVA) Q1 2021 earnings results | AlphaStreet

TEVA PHARMACEUTICAL INDUSTRIES LIMITED : TEVA Stock Price | US8816242098 |  MarketScreener
TEVA PHARMACEUTICAL INDUSTRIES LIMITED : TEVA Stock Price | US8816242098 | MarketScreener

DEF 14A
DEF 14A

Does Teva Pharmaceutical Industries (NYSE:TEVA) Have A Healthy Balance  Sheet? | Nasdaq
Does Teva Pharmaceutical Industries (NYSE:TEVA) Have A Healthy Balance Sheet? | Nasdaq

Teva Pharmaceutical Industries Limited 2022 Q3 - Results - Earnings Call  Presentation (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical Industries Limited 2022 Q3 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha

Online auction: Laboratory, R&D and analytical equipment from Merck, Eli  Lilly, Teva and leading global firms
Online auction: Laboratory, R&D and analytical equipment from Merck, Eli Lilly, Teva and leading global firms

Teva Reports First Quarter 2021 Financial Results | Business Wire
Teva Reports First Quarter 2021 Financial Results | Business Wire

Teva Pharmaceutical Stock: Prepare For Takeoff (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical Stock: Prepare For Takeoff (NYSE:TEVA) | Seeking Alpha

Teva Stock Skyrockets After Inking North Of $4 Billion In Opioid  Settlements | Investor's Business Daily
Teva Stock Skyrockets After Inking North Of $4 Billion In Opioid Settlements | Investor's Business Daily

DEF 14A
DEF 14A

DEF 14A
DEF 14A

Teva Pharmaceutical (TEVA) Names Richard Francis as New CEO | Nasdaq
Teva Pharmaceutical (TEVA) Names Richard Francis as New CEO | Nasdaq

Teva Reports Third Quarter 2020 Financial Results | Business Wire
Teva Reports Third Quarter 2020 Financial Results | Business Wire

Teva- Pharmaceutical Industries Ltd. - ADR Shares Near 52-Week High -  Market Mover | Nasdaq
Teva- Pharmaceutical Industries Ltd. - ADR Shares Near 52-Week High - Market Mover | Nasdaq

Teva Stock: Teva Guides To Its First Year Of Growth Since 2017, But There's  A Caveat | Investor's Business Daily
Teva Stock: Teva Guides To Its First Year Of Growth Since 2017, But There's A Caveat | Investor's Business Daily